by Pillr Health
Pillr Health is a leading provider of innovative solutions designed to optimize and streamline pharmacy operations. Our focus is on enhancing efficiency, reducing costs, and improving patient outcomes, particularly within the 340B program and beyond. Listen to leading 340B, technology and pharmacy professionals who provide clinical insights and the latest information to help support your 340B program.
Language
🇺🇲
Publishing Since
12/15/2022
Email Addresses
0 available
Phone Numbers
0 available
July 30, 2024
<p>In this episode of the 340B Insider podcast, Sumona discusses UW Medicine's new initiative to highlight the impact of the 340B program and share the multifaceted benefits of 340B in enhancing patient care and community health. She explains how the initiative was structured, the role of the 340B oversight committee, and the importance of creating a consistent narrative to share with various stakeholders. This initiative has allowed UW Medicine to showcase the significant benefits of the 340B program, such as providing substantial financial assistance for prescriptions, supporting specialized clinics for vulnerable populations, and enhancing overall patient outcomes. We invite you to learn from Sumona's first-hand experience and reach out to her with any questions as you consider rolling out similar initiatives at your Covered Entity.</p>
March 18, 2024
<p class="p1">In this podcast episode, we are joined by Ted Slafsky, Publisher and CEO of the 340B Report and Founder & Principal of Wexford Solutions LLC.</p> <p class="p1">During our discussion, Ted highlights ongoing federal court decisions and updates listeners on states like Arkansas and Louisiana, where laws restoring 340B pricing have faced legal challenges but are making progress. We also cover a recent and pressing topic - the "Sustain 340B Act," a draft senate bill addressing various aspects of the program, including contract pharmacy restrictions and patient definition. Additionally, Ted discusses the significance of Senator John Thune's involvement in the bill, and how changes in Senate leadership have the potential to impact the program's future.</p>
December 12, 2023
<p class="p1">In this episode of the RxStrategies 340B Insider Podcast, hosts Jonathan Ghenn and Rhodie Smith engage in a conversation with Rob Johnson, a pharmacist and entrepreneur who founded RPh Innovations, a company providing professional support services to 340B covered entities.</p> <p class="p1">Rob shares insight into the evolving dynamics of the 340B program over his years of experience, highlighting the increasing complexity, especially with manufacturer blocks. The discussion delves into the value RPHi brings to covered entities, focusing on areas such as price file verifications, eligibility, and optimizing savings potential. Rob also addresses the challenges around in-house pharmacies and shares his perspective on the future of the 340B program.</p>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
